Medicines Formulary

Medicines A–Z

N

Drug name	NICE TAs	Comments
Nab-paclitaxel
N-Acetylcysteine nebulised
Naftidrofuryl capsules
Naldemedine (Rizmoic®)	TA651 - Naldemedine for treating opioid-induced constipation
Nalmefene	TA325 - Nalmefene for reducing alcohol consumption in people with alcohol dependence	Restricted to specialist substance misuse services
Naloxegol (Moventig®)	TA345 - Naloxegol for treating opioid-induced constipation	For treating opioid-induced chronic constipation - use in line with NICE
Naloxone
Naloxone injection
Naloxone nasal spray (Nyxoid®)
Naltrexone tablets	TA115 - Naltrexone for the management of opioid dependence

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.